Johnson & Johnson (JNJ) P/E Ratio History
Historical price-to-earnings valuation from 1990 to 2025
Loading P/E history...
JNJ Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 6, 2026, Johnson & Johnson (JNJ) trades at a price-to-earnings ratio of 39.0x, with a stock price of $225.59 and trailing twelve-month earnings per share of $10.34.
The current P/E is 77% above its 5-year average of 22.0x. Over the past five years, JNJ's P/E has ranged from a low of 9.6x to a high of 33.5x, placing the current valuation at the 100th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.2x, JNJ trades at a 76% premium to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 171.0x.
Relative to the broader market, JNJ commands a significant premium over the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our JNJ DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
JNJ P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $152B | 11.4Lowest | 0.38Best | +134% | |
| $150B | 19.4 | - | -4% | |
| $279B | 15.5 | 0.73 | +8% | |
| $934B | 43.1 | 1.49 | +96% | |
| $116B | 16.5 | - | +178%Best | |
| $365B | 87.0 | - | -1% | |
| $278B | 20.2 | 1.32 | +22% | |
| $113B | 35.1 | 2.36 | +8% | |
| $100B | 21.5 | - | +31% | |
| $83B | 28.9 | - | +55% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
JNJ Historical P/E Data (1990–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q3 | Sun Sep 28 2025 00:00:00 GM | $179.71 | $10.36 | 17.3x | -44% |
| FY2025 Q2 | Sun Jun 29 2025 00:00:00 GM | $152.41 | $9.35 | 16.3x | -47% |
| FY2025 Q1 | Sun Mar 30 2025 00:00:00 GM | $163.71 | $8.99 | 18.2x | -41% |
| FY2024 Q4 | Sun Dec 29 2024 00:00:00 GM | $145.05 | $5.79 | 25.1x | -19% |
| FY2024 Q3 | Sun Sep 29 2024 00:00:00 GM | $161.40 | $6.05 | 26.7x | -13% |
| FY2024 Q2 | Sun Jun 30 2024 00:00:00 GM | $146.16 | $15.15 | 9.6x | -69% |
| FY2024 Q1 | Sun Mar 31 2024 00:00:00 GM | $158.19 | $15.18 | 10.4x | -66% |
| FY2023 Q4 | Sun Dec 31 2023 00:00:00 GM | $156.74 | $13.81 | 11.3x | -63% |
| FY2023 Q3 | Sun Oct 01 2023 00:00:00 GM | $155.75 | $13.47 | 11.6x | -62% |
| FY2023 Q2 | Sun Jul 02 2023 00:00:00 GM | $165.52 | $4.94 | 33.5x | +9% |
| FY2023 Q1 | Sun Apr 02 2023 00:00:00 GM | $155.00 | $4.78 | 32.4x | +5% |
| FY2022 Q4 | Sat Dec 31 2022 00:00:00 GM | $176.65 | $6.74 | 26.2x | -15% |
Average P/E for displayed period: 30.8x
Full JNJ Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
Should I Buy JNJ Right Now?
Bull case, key risks, Wall St analyst verdict, and what council investors are saying — updated daily.
See JNJ's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs JNJ Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare JNJ vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonJNJ — Frequently Asked Questions
Quick answers to the most common questions about buying JNJ stock.
Is JNJ stock overvalued or undervalued?
JNJ trades at 39.0x P/E, above its 5-year average of 22.0x. The 100th percentile ranking indicates a premium to historical valuation.
How does JNJ's valuation compare to peers?
Johnson & Johnson P/E of 39.0x compares to sector median of 22.2x. The premium reflects expected growth above peers.
What is JNJ's PEG ratio?
JNJ PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 1990-2025.